Organogenesis Holdings Inc (ORGO)
4.00
-0.43
(-9.71%)
USD |
NASDAQ |
Nov 14, 16:00
4.00
0.00 (0.00%)
After-Hours: 20:00
Organogenesis Holdings Total Assets (Quarterly): 443.16M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 443.16M |
| March 31, 2024 | 458.48M |
| December 31, 2023 | 460.02M |
| September 30, 2023 | 462.65M |
| June 30, 2023 | 450.31M |
| March 31, 2023 | 446.11M |
| December 31, 2022 | 449.36M |
| September 30, 2022 | 457.27M |
| June 30, 2022 | 456.36M |
| March 31, 2022 | 436.27M |
| December 31, 2021 | 443.26M |
| September 30, 2021 | 370.42M |
| June 30, 2021 | 355.56M |
| March 31, 2021 | 319.18M |
| December 31, 2020 | 290.22M |
| September 30, 2020 | 246.43M |
| June 30, 2020 | 216.49M |
| Date | Value |
|---|---|
| March 31, 2020 | 208.34M |
| December 31, 2019 | 220.69M |
| September 30, 2019 | 174.64M |
| June 30, 2019 | 168.07M |
| March 31, 2019 | 176.45M |
| December 31, 2018 | 163.68M |
| September 30, 2018 | 316.31M |
| June 30, 2018 | 314.98M |
| March 31, 2018 | 313.79M |
| December 31, 2017 | 148.72M |
| September 30, 2017 | 312.06M |
| June 30, 2017 | 311.56M |
| March 31, 2017 | 311.24M |
| December 31, 2016 | 311.44M |
| September 30, 2016 | 0.8219M |
| June 30, 2016 | 0.5935M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
208.34M
Minimum
Mar 2020
462.65M
Maximum
Sep 2023
378.45M
Average
443.16M
Median
Jun 2024
Total Assets (Quarterly) Benchmarks
| Poseida Therapeutics Inc | 298.69M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
| Theriva Biologics Inc | 42.39M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 179.66M |
| Shareholders Equity (Quarterly) | 263.50M |
| Debt to Equity Ratio | 0.2409 |
| Current Ratio | 2.732 |
| Net Debt Paydown Yield | 0.34% |